Now, let's consider whether a stock split may be in the cards for Lilly. As mentioned, the pharma giant has seen its stock ...
Standard Lithium Ltd. (NYSEA:SLI) is a company focused on developing lithium brine projects in the United States to produce ...
TipRanks on MSN
Luye Pharma Gains FDA Approval for New CNS Drug Trials
An update from Luye Pharma Group ( ($HK:2186) ) is now available. Luye Pharma Group Ltd. has received FDA clearance to initiate clinical trials in ...
Standard Lithium Ltd. recently reported financial results for the third quarter and nine months ended September 30, 2025, highlighting a US$6.12 million net loss for the quarter and a US$12.65 million ...
Detailed price information for Standard Lithium Ltd (SLI-A) from The Globe and Mail including charting and trades.
Albemarle surges with China lithium prices surged after Li Liangbin, chairman of major Chinese producer Ganfeng Lithium, said ...
Detailed price information for Standard Lithium Ltd (SLI-A) from The Globe and Mail including charting and trades.
TipRanks on MSN
Standard Lithium Ltd. Reports Q3 2025 Financial Results
The latest update is out from Standard Lithium Ltd ( (TSE:SLI) ).
ZURICH, Nov 8 (Reuters) - Swatch Group (UHR.S), opens new tab will be removed from the benchmark Swiss Leader Index (SLI) next month, stock exchange operator SIX said, after a decline in the ...
The average one-year price target for Standard Lithium (NYSEAM:SLI) has been revised to $4.29 / share. This is an increase of 16.50% from the prior estimate of $3.69 dated September 29, 2025. The ...
Standard Lithium Ltd (NYSE:SLI) is trading lower Friday morning after the company announced the pricing of a previously announced underwritten public offering. What To Know: The company will issue ...
Standard Lithium Ltd. (NYSEAMERICAN: SLI) shares fell 13.73% in after-hours trading Thursday, slipping to $4.65. Check out the current price of SLI stock here. The sharp decline followed the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results